TrialEuropean journal of cancer (Oxford, England : 1990)2021

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.

Laura Mansi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.